Not applicableWithdrawnNCT06554730What this trial is testingMSD Belzutifan PASWho this might be right forVon Hippel Lindau Disease Merck Sharp & Dohme LLC
Not applicableStudy completedNCT00132704What this trial is testingAn Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationWho this might be right forOvarian NeoplasmsColorectal NeoplasmsMelanoma+2 more Memorial Sloan Kettering Cancer Center 149
Not applicableLooking for participantsNCT05225428What this trial is testingVideo Education With Result Dependent dIsclosureWho this might be right forGenetic TestingBreast CancerOvarian Cancer+6 more Dana-Farber Cancer Institute 1,020
Not applicableUnknownNCT03053999What this trial is testingVariables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)Who this might be right forMultiple Endocrine NeoplasiaPancreatic Neuroendocrine TumorsHyperparathyroidism M.D. Anderson Cancer Center 53
Early research (Phase 1)Ended earlyNCT06270082What this trial is testingStudy of IK-595 in RAS- or RAF-altered Advanced TumorsWho this might be right forSolid Tumor, AdultColorectal CancerPancreatic Cancer+7 more Ikena Oncology 75
Not applicableWithdrawnNCT02309632What this trial is testingPancreatic Cancer Screening of High-Risk Individuals in ArkansasWho this might be right forPancreatic NeoplasmsPeutz-Jegher's SyndromeBRCA1 Gene Mutation+5 more University of Arkansas
Not applicableLooking for participantsNCT04498767What this trial is testingStereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)Who this might be right forGynecologic CancerSkin CancerHead and Neck Cancer+12 more European Organisation for Research and Treatment of Cancer - EORTC 200
Testing effectiveness (Phase 2)UnknownNCT03279601What this trial is testingStudy to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine TumorWho this might be right forNeuroendocrine Tumors Peking University 148
Testing effectiveness (Phase 2)Looking for participantsNCT06330064What this trial is testingEvaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)Who this might be right forRecurrent or Metastatic Solid Tumors Daiichi Sankyo 520
Early research (Phase 1)Study completedNCT00844064What this trial is testingSafety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2Who this might be right forPancreatic NeoplasmsMelanomaColorectal Neoplasms Isarna Therapeutics GmbH 62
Testing effectiveness (Phase 2)Looking for participantsNCT01174121What this trial is testingImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic CancerWho this might be right forMetastatic Colorectal CancerMetastatic Pancreatic CancerMetastatic Ovarian Cancer+2 more National Cancer Institute (NCI) 332
Early research (Phase 1)Ended earlyNCT07121829What this trial is testingTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsWho this might be right forMelanomaSolid TumorPilocytic Astrocytoma+7 more Day One Biopharmaceuticals, Inc. 44
Not applicableUnknownNCT03043508What this trial is testingOverall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)Who this might be right forGenetic MutationMEN1 M.D. Anderson Cancer Center 45
Not applicableLooking for participantsNCT06041009What this trial is testingPancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other ExaminationsWho this might be right forPancreatic Ductal AdenocarcinomaPancreatic DiseasesPancreatic Elastase 1+3 more Qilu Hospital of Shandong University 2,100
Testing effectiveness (Phase 2)Looking for participantsNCT05997056What this trial is testingTrial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR InhibitorsWho this might be right forNeuroendocrine TumorsNETPancreatic Neuroendocrine Tumor+2 more Aadi Bioscience, Inc. 21
Testing effectiveness (Phase 2)Ended earlyNCT01628913What this trial is testingEfficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine TumorsWho this might be right forPancreatic Neuroendocrine Tumors (pNET) Novartis Pharmaceuticals 62
Testing effectiveness (Phase 2)Study completedNCT02162446What this trial is testing68Ga-OPS202 Study for Diagnostic Imaging of GEP NETWho this might be right forGastroenteropancreatic Neuroendocrine Tumors Ipsen 12
Not applicableLooking for participantsNCT06605404What this trial is testingPan-tumor MRD StudyWho this might be right forMuscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more Paradigm Health 1,350
Not applicableUnknownNCT03741517What this trial is testingBiomarker Study of Pancreatic Neuroendocrine TumoursWho this might be right forPancreatic Neuroendocrine Tumor Uppsala University 40
Testing effectiveness (Phase 2)Ended earlyNCT02273752What this trial is testingPharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerWho this might be right forEstrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more Emory University 2